@article{Phromkamdang_Sirilak_2022, title={Effects of Pharmaceutical Care on Clinical Outcomes in Patients with Chronic Kidney Disease in Wiang Haeng Hospital, Chiang Mai Province}, volume={3}, url={https://he02.tci-thaijo.org/index.php/jnphr/article/view/259668}, abstractNote={<p>The objective of this retrospective study was to examine the effects of a pharmaceutical care program on clinical outcomes in patients with stage 3 or 4 Chronic Kidney Disease (CKD) and having diabetes mellitus or hypertension or both as co-morbidities. The pharmaceutical care program included finding drug-related problems, assessing medical adherence, reviewing prescription, adjusting a drug’s dosage, and guiding on drug education.  The study was conducted by studying medical records between October 1, 2017 and September 30, 2019. The study was to compare clinical outcomes in a single group of participants before and after receiving a pharmaceutical care program for a one-year period that started from October 1, 2018. Clinical outcomes, included levels of blood pressure, blood pressure (BP), fasting blood sugar (FBS), glycosylated hemoglobin (HbA1C), total cholesterol (TC), triglyceride (TG), high-density lipoprotein (HDL) and low-density lipoprotein (LDL). Data was analyzed by descriptive analysis. Paired t-test was used to compare kidney function blood values before and after receiving a pharmaceutical care program.</p> <p>The study showed that the average age of patients was 71 years old (S.D.=10.7) and 51.7% were females. Most of patients (95.8%) were at stage 3 CKD. The average estimated glomerular filtration rate (eGFR) was significantly improved around 51.85 (S.D.=14.71) at baseline testing to 54.84 (S.D.=16.53) ml/min/1.73m2 at 12-month follow up (p-value=0.009). The average serum creatinine level had decreased significantly from 1.33 (S.D.=0.41) at the baseline to 1.27 (S.D.=0.39) mg/dL at 12-month follow up (p-value=0.001). This study suggested that the pharmaceutical care program is an effective tool to slow the deterioration rate of kidney function in patients with CKD and having diabetes mellitus or hypertension or both as co-morbidities.</p>}, number={1}, journal={Journal of Nursing and Public Health Research}, author={Phromkamdang, Kanyarat and Sirilak, Thitipong}, year={2022}, month={Dec.}, pages={1–19} }